Skip to main content
OpenTrials
Completed

NCT Number: NCT01312987

Improving Nutrition and Health Outcomes in Intibuca, Honduras (MANI I)

The purpose of this research study is to assess what impact an integrated educational and feeding intervention delivered to infants and children has on growth (weight and height), development (cognitive and gross motor), nutrition (dietary behaviors, food insecurity, and micronutrient status - folate, iron, zinc, vitamin A, vitamin D), and morbidity (respiratory and diarrheal) outcomes. A randomized community trial was used to implement a nutrition intervention program consisting of monthly education sessions, a lipid-based nutrition supplement, and food vouchers for local staples.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 month–18 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All healthy children between the ages of 5-18 months old and their mothers who are residents of the municipalities of Santa Lucia, Magdalena and San Antonio who do not present any of the medical conditions listed in the exclusion criteria.
  • Mothers have understood and signed consent forms to enable their children to participate in the study. They were willing to have their child participate in one or more blood draws, bi-monthly sessions: 1) nutrition classes and food voucher and lipid-based nutritional supplement and 2) height/weight monitoring, dietary intake questionnaire, and health outcome information. As well as the additional data assessments necessary to be considered active participants in the study.

Exclusion criteria

  • Children with congenital anomalies, mental retardation, severe physical handicap, under-nutrition caused by medical conditions that contribute to under-nutrition such as heart disease, kidney failure, face and throat problems that interfere with swallowing, medical problems interfering with the absorption of food, chronic diseases such as tuberculosis, etc.
  • Children with a known allergy to peanuts and eggs will also be excluded from the study, 30% of children with known allergies to nuts also have an allergy to eggs.
  • Plans to move or change their place of residence outside of the study region in the next 2 months would make them ineligible.
  • Mothers who are younger than 16 years of age will be excluded from the study. Women younger than 16 might not understand the consent process and the importance of following the guidelines established in the research, therefore we chose not to include this group as "eligible" participants.
  • Children who are <= -2 standard deviations below the norm for z score for weight for age. These children are severely malnourished and need to be carefully followed under the supervision of a qualified health care provider.

Treatment and study plan

Lipid-based nutritional supplement

Dietary Supplement

After gradual introduction of the lipid-based nutritional supplement, daily dose per child is as follows:

3 teaspoons 3 x day for children younger than 12 months 4.5 teaspoons 3 x day for children older than 12 months

Other names: Plumpy'doz®

Primary outcomes

  1. Change from baseline in height at 12 months

    Time frame: Baseline to month 12

    Participating children were measured by trained staff every month during the 12 month intervention.

  2. Change from baseline in hemoglobin status at 12 months

    Time frame: Baseline to month 12

    Hemoglobin status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

  3. Change from baseline in serum transferrin status at 12 months

    Time frame: Baseline to month 12

    Serum transferritin was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

  4. Change from baseline in C-Reactive Protein levels at 12 months

    Time frame: Baseline to month 12

    C-Reactive Protein was measured from dried blood spots collected at baseline, month 6, and month 12 of the intervention.

  5. Change from baseline in weight at 12 months

    Time frame: Baseline to month 12

    Participating children were weighed by trained staff every month during the 12 month intervention.

Secondary outcomes

  1. Change from baseline in zinc levels at 12 months

    Time frame: Baseline to month 12

    Zinc status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

  2. Change from baseline in food insecurity status at 12 months

    Time frame: Baseline to month 12

    Assessment teams administered a scored questionnaire at baseline and month 12 of the intervention.

  3. Change from baseline in dietary intake based on 24-Hour Food Recall at 12 months

    Time frame: Baseline to month 12

    Assessment teams administered a 24-Hour Food Recall every month of the intervention.

  4. Change from baseline in various health outcomes at 12 months

    Time frame: Baseline to month 12

    Assessment teams administered a scored questionnaire every month of the intervention.

  5. Change from baseline in acceptability of nutrition supplement at 12 months

    Time frame: Baseline to month 12

    Assessment teams administered a scored questionnaire at baseline, month 6, and month 12 of the intervention

  6. Change from baseline in folate status at 12 months

    Time frame: Baseline to month 12

    Folate status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

  7. Change from baseline in vitamin B12 status at 12 months

    Time frame: Baseline to month 12

    Vitamin B12 was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

Sponsors and collaborators

Lead sponsor

Shoulder to Shoulder

Other

Collaborators

  • The Mathile Institute for the Advancement of Human Nutrition

Registry information

Official study title

Improving Nutrition and Health Outcomes in Intibuca, Honduras

Acronym: MANI I

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Mar 11, 2011
Registry last updated
Aug 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.